Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 CAD | 0.00% | +1.15% | +3.53% |
Apr. 10 | Spectral Medical Updated on Tigris Trial | MT |
Apr. 10 | Spectral Medical Brief: Providing Tigris Trial Update; 101 patients enrolled | MT |
Sales 2024 * | 1.4M 1.02M | Sales 2025 * | 2.5M 1.82M | Capitalization | 123M 89.35M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 87.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 49.2 x |
P/E ratio 2024 * |
-11
x | P/E ratio 2025 * |
-22
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.49% |
Latest transcript on Spectral Medical Inc.
1 day | -1.12% | ||
Current month | -6.38% | ||
1 month | +4.76% | ||
3 months | -12.00% | ||
6 months | +41.94% | ||
Current year | +3.53% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Seto
CEO | Chief Executive Officer | - | 19-08-01 |
Paul Walker
CHM | Chairman | - | 01-03-31 |
John Kellum
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Walker
CHM | Chairman | - | 01-03-31 |
Anthony Bihl
BRD | Director/Board Member | 67 | 08-02-29 |
Janelle D'Alvise
BRD | Director/Board Member | 69 | 21-11-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.44 | 0.00% | 500 |
24-04-17 | 0.44 | -1.12% | 19,520 |
24-04-16 | 0.445 | -3.26% | 18,523 |
24-04-15 | 0.46 | +4.55% | 38,316 |
24-04-12 | 0.44 | +1.15% | 7,000 |
Delayed Quote Toronto S.E., April 17, 2024 at 03:14 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.53% | 89.06M | |
+28.79% | 676B | |
+24.92% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.79% | 210B | |
-0.09% | 204B | |
-9.53% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- EDT Stock